Latest Genzyme Stories
- Stowe to be Joined by Leading Neurologists and People Living with the Disease for Live Events Nationwide - CAMBRIDGE, Mass., Oct.
CARLSBAD, Calif., Sept. 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has earned a $4 million milestone payment from Achaogen, Inc.
Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and treatment MONTREAL, Sept.
-- 2Q Revenue Increased 71%, Compared to Prior Year -- SOUTH SAN FRANCISCO, Calif., Aug.
PARIS, July 31, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014.
STOCKHOLM, July 3, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, is very pleased to announce that Mrs Ann-Tove Kongsnes,
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- In medieval musical notation, a sign or neume denoting a shake or trill.